5 mins Welcome and Introductions
25 mins Exploring the Evolving Role of Actionable Mutations in the Management and Treatment of NSCLC
25 mins Using Biomarkers to Identify Treatment Targets in NSCLC: Case-based Discussions
5 mins Audience Q&A

Target Audience

Healthcare professionals who diagnose and manage patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists, advanced practice nurses, physicians’ assistants, nurses, and pharmacists.